Angiogenesis imaging with vascular-constrained particles: the why and how

Area of Science:

• Biomedical imaging
• Oncology
• Vascular biology

Background:

• Angiogenesis is crucial in cancer and other diseases.
• Current antiangiogenic therapies have limitations like cost and side effects.
• Genomic profiling and biomarker detection necessitate advanced imaging for early risk stratification.

Purpose of the Study:

• To explore novel noninvasive biomedical imaging approaches.
• To enhance quantitative characterization of angiogenesis-related pathologies.
• To integrate diagnostic and therapeutic capabilities (theranostics).

Main Methods:

• Review of emerging molecular imaging techniques.
• Focus on vascular-constrained contrast platforms.
• Exploration of theranostic agents.

Main Results:

• Development of imaging methods for sensitive and specific disease detection.
• Potential for improved patient segmentation and risk stratification.
• Integration of imaging with targeted antiangiogenic therapy.

Conclusions:

• Biomedical imaging is evolving to meet the needs of personalized medicine in angiogenesis-related diseases.
• Theranostic approaches offer a promising avenue for combined diagnosis and treatment.
• Vascular-constrained contrast platforms are key to advancing these imaging strategies.